0001513160-11-000056.txt : 20110901 0001513160-11-000056.hdr.sgml : 20110901 20110901190025 ACCESSION NUMBER: 0001513160-11-000056 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110831 FILED AS OF DATE: 20110901 DATE AS OF CHANGE: 20110901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Saloff David CENTRAL INDEX KEY: 0001375530 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-08092 FILM NUMBER: 111072001 MAIL ADDRESS: STREET 1: C/O GMID STREET 2: 12100 WILSHIRE BLVD., SUITE 800 CITY: LOS ANGELES STATE: CA ZIP: 90025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OXIS INTERNATIONAL INC CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 468 N. CAMDEN DR. STREET 2: 2ND FLOOR CITY: BEVERLY HILLS STATE: CA ZIP: 90210 BUSINESS PHONE: (310) 551-4020 MAIL ADDRESS: STREET 1: 468 N. CAMDEN DR. STREET 2: 2ND FLOOR CITY: BEVERLY HILLS STATE: CA ZIP: 90210 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 4 1 primary_doc.xml PRIMARY DOCUMENT X0304 4 2011-08-31 0 0000109657 OXIS INTERNATIONAL INC OXIS.OB 0001375530 Saloff David 1 1 0 0 Chief Executive Officer Common Stock Option 0.0535 2011-08-31 4 A 0 538713 0.0535 A 2021-08-31 Common Stock 538713 1316491 D David Saloff received a non-qualified stock option to purchase 538,713 shares of Common Stock under the Issuer's 2010 Equity Incentive Plan, in connection with his appointment as Chief Executive Officer of the Company. The options vest and become exercisable in equal quarterly installments during the one-year period following the date of grant. The options have a term of 10 years from the date of grant. /s/ David Saloff 2011-09-01